I have a diagnosed case of lean PCOS and need a critical review of the Ovasitol inositol powder by Theralogix, including whether the 40 to 1 myo-inositol to D-chiro-inositol ratio is backed by recent endocrinology studies.
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
I have a diagnosed case of lean PCOS and need a critical review of the Ovasitol inositol powder by Theralogix, including whether the 40 to 1 myo-inositol to D-chiro-inositol ratio is backed by recent endocrinology studies.
3 real searches · 1 real-search pass
2023 international evidence-based guideline PCOS inositol 40:1 myo-inositol D-chiro-inositol evidence recommendationGoogle ↗
OBSERVED
2024 2025 randomized trial myo-inositol D-chiro-inositol 40:1 PCOS systematic review meta-analysisGoogle ↗
OBSERVED
Theralogix Ovasitol supplement facts 2000 mg myo-inositol 50 mg D-chiro-inositol third party testingGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2023 international evidence-based guideline PCOS inositol 40:1 myo-inositol D-chiro-inositol evidence recommendation Google ↗
2024 2025 randomized trial myo-inositol D-chiro-inositol 40:1 PCOS systematic review meta-analysis Google ↗
Theralogix Ovasitol supplement facts 2000 mg myo-inositol 50 mg D-chiro-inositol third party testing Google ↗
- Ovasitol® Inositol Powder · theralogix.com
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome | The Journal of Clinical Endocrinology & Metabolism · academic.oup.com
- Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines · pubmed.ncbi.nlm.nih.gov
- Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines | The Journal of Clinical Endocrinology & Metabolism · academic.oup.com
- Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines · pmc.ncbi.nlm.nih.gov
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome · pubmed.ncbi.nlm.nih.gov
- 2024 Inositol Systematic Review and Meta-analysis – Journal of Clinical Endocrinology & Metabolism · pmc.ncbi.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2023 international evidence-based guideline PCOS inositol 40:1 myo-inositol D-chiro-inositol evidence recommendation OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
2024 2025 randomized trial myo-inositol D-chiro-inositol 40:1 PCOS systematic review meta-analysis OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
Theralogix Ovasitol supplement facts 2000 mg myo-inositol 50 mg D-chiro-inositol third party testing OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |